"Natco Pharma gets USFDA nod for Armodafinil tablets "

Drug firm Natco PharmaBSE 1.01 % has received the final approval from the US health regulator for generic Armodafinil tablets, used as wakefulness promoting agent, and plans to launch the product immediately in the US

Spotlight

Other News

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Spotlight

Resources